Treatment of multiresistant prolactinomas with a combination of cabergoline and octreotide LAR.
Saved in:
| Title: | Treatment of multiresistant prolactinomas with a combination of cabergoline and octreotide LAR. |
|---|---|
| Authors: | Sosa-Eroza E; Endocrinology Service and the Experimental Endocrinology Unit, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, MX, USA., Espinosa E; Endocrinology Service and the Experimental Endocrinology Unit, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, MX, USA., Ramírez-Rentería C; Endocrinology Service and the Experimental Endocrinology Unit, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, MX, USA., Mendoza V; Endocrinology Service and the Experimental Endocrinology Unit, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, MX, USA., Arreola R; Pathology Department, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, MX, USA., Mercado M; Endocrinology Service and the Experimental Endocrinology Unit, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, MX, USA. moises.mercado@endocrinologia.org.mx. |
| Source: | Endocrine [Endocrine] 2018 Aug; Vol. 61 (2), pp. 343-348. Date of Electronic Publication: 2018 Jun 11. |
| Publication Type: | Clinical Trial; Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 9434444 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-0100 (Electronic) Linking ISSN: 1355008X NLM ISO Abbreviation: Endocrine Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1559-0100 |
|---|---|
| DOI: | 10.1007/s12020-018-1638-9 |
